186 related articles for article (PubMed ID: 37202599)
41. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.
Shi H; Chen Z; Dong S; He R; Du Y; Qin Z; Zhou W
BMC Gastroenterol; 2022 Jun; 22(1):279. PubMed ID: 35658912
[TBL] [Abstract][Full Text] [Related]
42. Nomogram predicting the cancer-specific survival of early-onset colorectal cancer patients with synchronous liver metastasis: a population-based study.
Ding X; Yang X; Wu D; Huang Y; Dai Y; Li J; Chang W; Chi M; Tian S
Int J Colorectal Dis; 2022 Jun; 37(6):1309-1319. PubMed ID: 35524790
[TBL] [Abstract][Full Text] [Related]
43. Survival outcome and prognostic factors for colorectal cancer with synchronous bone metastasis: a population-based study.
Li X; Hu W; Sun H; Gou H
Clin Exp Metastasis; 2021 Feb; 38(1):89-95. PubMed ID: 33420873
[TBL] [Abstract][Full Text] [Related]
44. Prognostic model for predicting overall survival in patients with glioblastoma: an analysis based on the SEER database.
Luo Y; Hao L; Liu C; Xiang Y; Han X; Bo Y; Han Z; Wang Z; Wang Y
J Investig Med; 2023 Apr; 71(4):439-447. PubMed ID: 36935629
[TBL] [Abstract][Full Text] [Related]
45. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
Li Y; Tao T; Liu Y
BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
[TBL] [Abstract][Full Text] [Related]
46. Construction and validation of a prognostic nomogram in metastatic breast cancer patients of childbearing age: A study based on the SEER database and a Chinese cohort.
Ma X; Xing Y; Li Z; Qiu S; Wu W; Bai J
Front Oncol; 2022; 12():999873. PubMed ID: 36505800
[TBL] [Abstract][Full Text] [Related]
47. Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database.
Zhang M; Li R; Zhang S; Xu X; Liao L; Yang Y; Guo Y
Front Surg; 2022; 9():1001791. PubMed ID: 36684133
[TBL] [Abstract][Full Text] [Related]
48. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract][Full Text] [Related]
49. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
Xiao R; Liu C; He W; Ma L
Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
[TBL] [Abstract][Full Text] [Related]
50. Establishment and validation of a prognostic nomogram for patients with early-onset stage I-II colon cancer.
Li D
World J Surg Oncol; 2023 Mar; 21(1):103. PubMed ID: 36964525
[TBL] [Abstract][Full Text] [Related]
51. Prognostic Nomogram for Gastrointestinal Stromal Tumors after Surgery Based on the SEER Database.
Sun Q; Chen Y; Li T; Zhu X; Zhu G; Ni B; Gao R; Li J
Biomed Res Int; 2022; 2022():5639174. PubMed ID: 36420093
[TBL] [Abstract][Full Text] [Related]
52. A population-based study of synchronous distant metastases and prognosis in patients with PDAC at initial diagnosis.
Zhang L; Jin R; Yang X; Ying D
Front Oncol; 2023; 13():1087700. PubMed ID: 36776324
[TBL] [Abstract][Full Text] [Related]
53. Epidemiology and nomogram for predicting the cancer-specific survival of ovarian granulosa cell tumor: A seer database study.
Xia L; Qiu S; Kong FB; Lai J; Huang H; Hu H; Liu X; Ye Z; Cao J
J Gynecol Obstet Hum Reprod; 2023 Jun; 52(6):102601. PubMed ID: 37156420
[TBL] [Abstract][Full Text] [Related]
54. Construction of survival prediction model for elderly esophageal cancer.
Qie S; Shi H; Wang F; Liu F; Gu J; Liu X; Li Y; Sun X
Front Oncol; 2022; 12():1008326. PubMed ID: 36338725
[TBL] [Abstract][Full Text] [Related]
55. A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study.
Zhao W; Wu L; Zhao A; Zhang M; Tian Q; Shen Y; Wang F; Wang B; Wang L; Chen L; Zhao X; Dong D; Zhang L; Yang J
BMC Cancer; 2020 Oct; 20(1):982. PubMed ID: 33046035
[TBL] [Abstract][Full Text] [Related]
56. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
57. Construction and validation of prognostic nomogram for metaplastic breast cancer.
Li Y; Chen D; Xuan H; Dragomir MP; Calin GA; Meng X; Chen M; Jin H
Bosn J Basic Med Sci; 2022 Feb; 22(1):131-139. PubMed ID: 34247567
[TBL] [Abstract][Full Text] [Related]
58. Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis.
Zhao R; Dai Y; Li X; Zhu C
Sci Rep; 2022 Mar; 12(1):4011. PubMed ID: 35256719
[TBL] [Abstract][Full Text] [Related]
59. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma.
Li W; Xiao Y; Xu X; Zhang Y
Ann Surg Oncol; 2021 Jul; 28(7):3490-3500. PubMed ID: 33191484
[TBL] [Abstract][Full Text] [Related]
60. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years.
Liu Q; Li W; Xie M; Yang M; Xu M; Yang L; Sheng B; Peng Y; Gao L
Bosn J Basic Med Sci; 2021 Oct; 21(5):620-631. PubMed ID: 33485294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
